Antibody Patterns Spotted a Decade Before IBD Diagnosis
Immune system changes can be detected in the blood up to a decade before a patient develops chronic inflammatory bowel disease (IBD), according to a study published in the medical journal Gut. Researchers analyzed roughly 2,000 blood samples from 500 US military personnel, uncovering distinct antibody patterns long before clinical symptoms like abdominal pain and diarrhea appeared.
Globally, at least four million people live with chronic inflammatory bowel disease, with up to 600,000 affected in Germany alone, where about 10,000 new diagnoses occur each year. The samples were taken from various intervals, including approximately ten, four, and two years prior to diagnosis, as well as at the time of disease onset. Scientists examined which antibodies directed against bacteria, viruses, foods, and bodily tissues were present in the blood. Lange Zeit konnten wir entzündliche Darmerkrankungen nur behandeln, nachdem bereits Schäden entstanden waren, und für viele Menschen ist es dann zu spät, said Dr. Arno Bourgonje. He noted that the disease can begin years before symptoms emerge because the immune system leaves detectable traces beforehand. Marinanne Radcliffe expressed hope that identifying at-risk individuals early will eventually enable treatment before intestinal damage occurs, or even prevent or delay the onset of the disease.
Contrasting Immune Profiles in Crohn’s and Colitis Ulcerosa
The research team examined blood samples taken up to 10 years prior to diagnosis. They compared 200 individuals who later developed Crohn’s disease, 200 who developed colitis ulcerosa, and 100 healthy control subjects.
In contrast, future colitis ulcerosa patients displayed different antibody patterns, including antibodies against a protein in the body itself.
The antibody patterns also provided indications regarding which individuals with Crohn’s disease would later develop a more complicated clinical course. “It is fascinating to see that a complicated course of Crohn’s disease at diagnosis is associated with a specific antibody profile – years before the first clinical symptoms,” said study leader Dr. Arno Bourgonje.
Computer Models Achieve High Predictive Accuracy
The international research team presented these findings at the UEG Week 2026 congress. Using a computer-based learning model, scientists successfully distinguished future IBD patients from healthy control subjects using blood samples drawn a decade before formal diagnosis.
The statistical predictive score reached 0.90 for Crohn’s disease and 0.84 for colitis ulcerosa, where values closer to 1 indicate higher predictive accuracy.
Caution Urged Before Clinical Adoption
Arno Bourgonje of the University Medical Center Groningen and the Icahn School of Medicine at Mount Sinai emphasized that the method is not yet ready for routine clinical application. He warned that the profiles do not yet allow reliable individual predictions and require validation across independent, diverse populations.
James Lindsay, a gastroenterology specialist not involved in the study, confirmed that the approach remains a research tool rather than a standard hospital screening test.
Professor James Lindsay explained that the study provides important insights into the causes of Crohn’s disease and colitis ulcerosa and can assist in identifying high-risk patients. Furthermore, additional research must clarify whether such a test provides added value over already known risk factors and other examinations, and whether it would genuinely improve treatment outcomes.